Cargando…
Identification of characteristics, risk factors, and predictors of recurrent LVAD thrombosis: conditions in HeartWare devices
BACKGROUND: Redictors of repetitive left-ventricular assist device (LVAD)-thrombosis have not been studied yet. METHODS: We identified predictors of recurrent LVAD thrombosis in HeartWare (HVAD) patients in a long-term study from 2010 until 2020. We included all patients with two or more thrombolysi...
Autores principales: | Gyoten, Takayuki, Morshuis, Michiel, Rojas, Sebastian V., Deutsch, Marcus-André, Schramm, René, Gummert, Jan F., Fox, Henrik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Japan
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8154821/ https://www.ncbi.nlm.nih.gov/pubmed/33337536 http://dx.doi.org/10.1007/s10047-020-01228-2 |
Ejemplares similares
-
Evolution of thrombolytic therapy in patients with HeartWare ventricular assist device thrombosis: a single-institutional experience
por: Fox, Henrik, et al.
Publicado: (2022) -
Successful repeated thrombolysis in a patient with HeartWare thrombosis – the importance of Doppler flow pattern
por: Paluszkiewicz, Lech, et al.
Publicado: (2014) -
Comparing short‐term outcome after implantation of the HeartWare® HVAD® and the Abbott® HeartMate 3®
por: Schramm, Rene, et al.
Publicado: (2020) -
Safety, Mortality, and Hemodynamic Impact of Patients with MitraClip Undergoing Left Ventricular Assist Device Implantation
por: Fox, Henrik, et al.
Publicado: (2021) -
Identifying patients at risk: multi‐centre comparison of HeartMate 3 and HeartWare left ventricular assist devices
por: Numan, Lieke, et al.
Publicado: (2023)